Primary malaria prevention on a large scale depends on two vector control interventions: indoor residual spraying (IRS) and insecticidetreated mosquito nets (ITNs). Historically, IRS has reduced malaria transmission in many settings in the world, but the health effects of IRS have never been properly quantified. This is important, and will help compare IRS with other vector control interventions.
African region (WHO 2008) . Ninety per cent of all malaria cases occur in sub-Saharan Africa, in areas of stable endemic transmission, and around 20% of all deaths in children have been attributed directly to malaria (Snow 1999) . The disease causes widespread premature death and suffering, imposes financial hardship on poor households, and holds back economic growth and improvements in living standards. The rapid spread of resistance first to chloroquine and now to sulfadoxine-pyrimethamine has greatly increased the cost and difficulty of malaria case management, particularly in Africa (RBM 2005) . Estimates have suggested that malaria costs the African countries US$12 billion annually and may considerably retard economic development (Sachs 2002) .
Primary prevention of malaria is essentially achieved through two main vector control interventions: indoor (house) residual insecticide spraying (IRS); and insecticide-treated (mosquito) nets (ITNs). The health effects of ITNs have been comprehensively summarized in two Cochrane Reviews, one for general populations (Lengeler 2004) and one for pregnant women (Gamble 2006) .
IRS has a long and distinguished history in malaria control. Using mainly dichloro-diphenyl-trichlorethane (DDT), malaria was eliminated or greatly reduced as a public health problem in Asia, Russia, Europe, and Latin America (Schiff 2002; Lengeler 2003; Roberts 2004) . IRS continues to be used in many parts of the world, with the services provided by the public health system or by a commercial company (usually for the benefit of its employees). There is no IRS programme known to us in which beneficiaries were expected to contribute financially.
A historical review of IRS in Southern Africa investigated the malaria situation before and after the introduction of IRS in South Africa, Swaziland, Namibia, Zimbabwe, and Mozambique, where it continues to protect 13 million people (Mabaso 2004) . After the implementation of control operations, spectacular reductions in malaria parameters and vector densities were recorded, and in certain instances the intervention led to local elimination. Another historical paper reviewed the health impacts of 36 successful IRS programmes in 19 countries throughout sub-Saharan Africa (Kouznetsov 1977) . The analyses compared parasite rates and other malariological outcomes before and after the operation in each of the five major eco-epidemiological zones and demonstrated substantial epidemiological benefits. Unfortunately, most of these studies simply documented time trends of malaria parameters with no appropriate control groups. This is also the case for the most recent programme impact assessments (Sharp 2002; Tseng 2008; Teklehaimanot 2009; Kleinschmidt 2009 ). Hence, while there is no doubt that IRS reduces malaria transmission and improves health outcomes, assessments up to the present day do not allow us to quantify the health effects.
IRS is thought to operate both through repelling mosquitoes from entering houses and by killing female mosquitoes that are resting inside houses after having taken a blood meal. This implies that IRS is most effective against mosquito species that are resting indoors (so called endophilic mosquitoes). Whereas ITNs show a high degree of personal protection, IRS relies largely on a vectorial mass effect: the increased mortality of adult vectors mostly following feeding leads to a reduction in transmission. Spraying needs to be carried out between once and three times per year; the timing depending on the insecticide and the seasonality of transmission in a given setting. Reviewing the advantages and disadvantages of each insecticide is beyond the scope of this review and can be found among other in Najera 2001.
IRS has the advantage of being able to make use of a much wider range of insecticide products in comparison to ITNs, for which pyrethroids are the only class of insecticide currently used. The World Health Organization (WHO) recommends a number of insecticides for individual residual spraying: DDT wettable powder (WP); malathion WP; fenitrothion WP; pirimiphos-methyl WP and emulsifiable concentrate (EC); bendiocarb WP; propoxur WP; alpha-cypermethrin WP & suspension concentrate (SC); cyfluthrin WP; deltamethrin WP; etofenprox WP; lambda-cyhalothrin capsule suspension (CS) and WP (WHOPES 2007) . This extended range of insecticides has important benefits for the management of insecticide resistance and hence the long-term sustainability of vector control (pyrethroid resistance has already been reported in many parts of tropical Africa and other parts of the world among populations of the major malaria vectors). The potentially adverse effects of insecticides used for IRS, especially DDT, is an important issue but one that is beyond the scope of this review.
Insecticide spraying is often done on a very large scale in order to maximize the mass effect of the insecticide; thus randomized controlled trial (RCT) designs may not always be feasible. However, controlled before-and-after studies (CBA) are clearly feasible, as are interrupted time series (ITS). We plan to include these three study designs while excluding simple pre-test and post-test studies with no concurrent controls, as the many potential biases make interpretation a problem. In all identified studies, allocation is expected to be by clusters rather than by individuals, since IRS is thought to be only effective if a large proportion of the population is protected. Two reviews have outlined the cost and health effects of IRS (Curtis 2001; Lengeler 2003) including a comparison of IRS against ITNs, but neither was conducted systematically or assessed the methodological quality of the included studies. Yukich 2008 presented standardized cost and cost-effectiveness assessments for the major ITN distribution models as well as for two IRS programmes in Southern Africa.
Here we aim to quantify the health benefits of IRS and to compare how IRS and ITNs differ in their ability to prevent ill-health from malaria.
O B J E C T I V E S
To quantify the impact of IRS alone, and to compare the relative impacts of IRS and ITNs, on key malariological parameters.
M E T H O D S

Criteria for considering studies for this review
Types of studies 1. RCTs and quasi-RCTs, randomized by cluster (cluster RCTs) and with three or more units per arm Bennett 2002; because of the mode of action of IRS (relying on a mass effect) we did not expect to find trials with individual randomization. 2. Controlled before-and-after studies with (1) two or more units per arm, (2) a contemporaneous control group, (3) monitoring of at least one transmission season before and after the intervention and (4) at least 60% coverage in the intervention arm. 3. Interrupted time series, with (1) a clearly defined point in time when the intervention occurred, (2) monitoring of at least two transmission seasons before and after the intervention and (3) at least 60% coverage in the intervention arm.
Types of participants
Children and adults living in rural and urban malarious areas. Excluded: studies examining the impact of IRS on soldiers, refugees, industrial workers and other special groups not representative of the general population.
Types of interventions
Interventions IRS carried out with insecticides recommended by the WHO at the correct dosage (WHO 2006; WHOPES 2007) . Selected insecticides should not have been used where site-specific insecticide resistance has been reported by the authors or in other available literature. To this effect, we searched for publications on insecticide resistance for each included trial site. Coverage of houses should have been above 60%. For the comparison with ITNs, we used the same inclusion criteria as in Lengeler 2004: mosquito nets treated with a synthetic pyrethroid insecticide at a minimum target dose of: 200 mg/m 2 for permethrin and etofenprox; 30 mg/m 2 for cyfluthrin; 20 mg/ m 2 for alphacypermethrin; and 10 mg/m 2 for deltamethrin and lambdacyhalothrin.
Controls
• Should not have received another insecticide-based malaria intervention.
• Should not have received a malaria-co-intervention(s) that differed from the intervention arm.
• ITNs only for the comparison IRS versus ITNs. For this comparison we made a distinction between situations in which ITNs were distributed to a population previously protected by IRS (which was obviously stopped for the time of the study) and situations in which the distribution of ITNs represents the first vector control intervention. Obviously, in a population previously protected by IRS the vector population would have been affected and it was assumed that this would have an effect on how well ITNs would work subsequently.
Types of outcome measures
Before the start of the review the following standardized outcomes were specified:
• All cause child mortality: children aged < 10 years, mortality determined by a prospective demographic surveillance system.
• Severe disease: site-specific definitions based on the WHO guidelines WHO 2000. The definition includes demonstration of parasitaemia. Cerebral malaria is defined as coma or prostration and/or multiple seizures. The cut-off for severe, lifethreatening anaemia is set at 5.1 g/L.
• Uncomplicated clinical malaria episodes: site-specific definitions, including fever, usually with parasitological confirmation, detected passively or actively. The case definition must be similar in all trial arms for the trial to be included in the analysis.
• Incidence of re-infections (after treatment): incidence rate of parasitaemia following radical cure; done with cohorts of children over 8 weeks.
• Parasite prevalence: obtained using a site-specific method for estimating parasitaemia, usually thick and/or thin blood smears.
• High density malaria prevalence: same as for parasite prevalence but with a site-specific parasitological cut-off.
• Haemoglobin levels (g/dL).
• Standard anthropometric measures: weight-for-age, heightfor-age, weight-for-height, skinfold thickness, and/or mid-upper arm circumference.
• Splenomegaly: measured using Hackett's scale from 1 to 5.
Search methods for identification of studies
We attempted to identify all relevant studies regardless of language or publication status (published, unpublished, in press, and in progress) . For details see Table 1 . 
Agencies and manufacturers
We contacted the following agencies, which have funded malaria control studies, for unpublished and ongoing trials: World Bank; UNICEF; World Health Organization; PAHO; and USAID. We also contacted the following manufacturers of insecticides: Bayer; BASF; Sumitomo; and Syngenta (June-July 2007). In June 2007 we also searched the US Armed Forces Pest Management Board web site for relevant trials, as well as all other sources that we identified in the process of the search.
Reference lists
We checked the reference lists of all studies identified by the above methods.
Data collection and analysis 1. Study selection
BP screened the results of the search strategy for potentially relevant studies and retrieved full articles. BP and FT independently assessed all identified studies for inclusion in the review, using an eligibility form based on the inclusion criteria. We scrutinized each report to avoid study duplication. We attempted to contact the study authors for clarification if it was unclear whether a study met the inclusion criteria or if there were issues with the study design. CL was asked to resolve any differences in opinion. We explain below the reasons for excluding studies ("Characteristics of excluded studies").
Assessment of methodological quality
BP/FT and CL independently evaluated the methodological quality of each included study. We attempted to contact the study authors if key information was missing or unclear, and resolved any disagreements through discussion.
RCTs
BP assessed the risk of bias of each included trial using The Cochrane Collaboration's risk of bias tool (Higgins 2008). We followed the guidance tool to make judgements on the risk of bias in six domains: sequence generation; allocation concealment; blinding (of participants, personnel, and outcome assessors); incomplete outcome data; selective outcome reporting; and other sources of bias. We categorized these judgements as 'yes' (low risk of bias), 'no' (high risk of bias), or 'unclear'.
Controlled before-and-after studies
We followed a strategy published elsewhere (Adinarayanan 2007); BP and FT independently assessed the quality of the included CBA study using a variety of criteria that we considered important and had specified a priori. These included: high intervention coverage in the community of interest (defined as at least 60% IRS coverage), presence of some type of comparison group with no intervention, reporting of outcomes for the entire community. We also attempted to identify concurrent control activities carried out at the same time or just before the IRS intervention by screening the primary study report and other relevant literature.
Interrupted time series
We used the criteria published elsewhere (EPOC 2002) to assess the study quality of the one included study. Criteria included protection against secular changes, sufficient data points to enable reliable statistical inference, protection against detection bias, and completeness of the data set. We also attempted to identify concurrent control activities carried out at the same time or just before the IRS intervention by screening the primary study report and other relevant literature.
Data extraction
BP independently extracted the data from each study into standardized data extraction forms. Again, we attempted to contact the corresponding author in any case of unclear or missing data.
RCTs
We extracted data according to the intention-to-treat principle: if any individual allocated to a treatment group was analysed as if the person had effectively received the intervention. If there was discrepancy between the number of units/participants randomized and the number of units/participants analysed we calculated the percentage losses to follow-up in each group and reported this information. In trials that compared ITNs with IRS, we assessed the differences in coverage between the different groups and presented this information in a table.
Cluster RCTs: Where results have been adjusted for clustering, we extracted the point estimate and the 95% confidence interval (CI). If the results were not adjusted for clustering, where possible we extracted outcome data as for individual RCTs and corrected the data in the analysis. We always recorded the number of clusters, the average size of clusters, and the unit of randomizations (eg household, village or other). The statistical methods used to analyse the trials are described below in section 4.1.
Controlled before-and-after studies
We extracted data using the same methods as for the RCTs, but we added information on the comparability of baseline characteristics and the time period of data collection.
Interrupted time series
We extracted data using the same methods as for the RCTs, but we added information on the comparability of baseline characteristics and additional information relating to the assessments made before and after the initiation of the intervention, using the approach recommended by EPOC 2002.
Data analysis 4.1. Cluster RCT
We had planned to meta-analyse the data from RCTs using Review Manager 5. However, the number of the trials was too low to meaningfully do such a meta-analysis. Hence we have only presented a narrative or tabulated summary of all study data.
All results are either presented as rates/proportions or as Risk Ratios (RR). From the RR the protective efficacy (PE; expressing the percentage reduction in an outcome) was derived using the formula: PE = (1-RR) * 100. Cluster RCTs with two or three arms and at least three clusters per arm were used for the comparisons of IRS versus no intervention or IRS versus ITNs. Three clusters per arm is considered a minimum (1) to minimize the risk of imbalances between groups, and (2) to allow appropriate statistical analysis (Bennett 2002) . The two other study designs (CBA and ITS) were used only for the comparison of IRS versus no intervention. Cluster trials require a more a complex analysis than that for individual RCTs (Hayes 2000) . Observations on participants in the same cluster tend to be correlated and that intra-cluster variation must be accounted for during the analysis. If this correlation is ignored in the analysis the measure of effect remains a valid estimate but the associated variance of the estimate would be underestimated, leading to unduly narrow CIs. For dichotomous outcomes expressed as risk, the results can be adjusted for clustering by multiplying the standard errors of the estimates by the square root of the design effect, where the design effect is calculated as DEff=1+(m-1)*ICC. This requires information such as the average cluster size (m) and the intra-cluster correlation coefficient (ICC). Unfortunately, the ICC was never reported by trial authors and hence cluster-adjustment was not always possible post-hoc. When the unadjusted CIs did not demonstrate a significant difference, then this is indicated. For dichotomous outcomes expressed as rates, we applied the methods described in (Bennett 2002) using a rate ratio calculated from the mean incidence rates for each treatment group. In the case of the study by Misra 1999 the authors used a geometric mean of the incidence rates and we applied the method described by Bennett 2002 using a rate ratio based on the geometric mean incidence rates for the outcomes "P. vivax and P. falciparum combined". Heterogeneity: With enough trials we would have assessed heterogeneity by (1) inspecting the forest plots to detect overlapping CIs, (2) applying the Chi 2 test with a P value of 0.10 indicating statistical significance, and (3) implementing the I 2 statistic with a value of 50% denoting moderate levels of heterogeneity. However, the number of trials was so low that combining trials was not possible. We stratified the presentation of the results into two groups on the basis of the entomological inoculation rate (EIR; number of infected bites per person per day) where < 1 was considered unstable malaria transmission, while settings with an EIR > 1 were considered to have stable transmission. A stratification on the basis of the main types of vectors, types of insecticides and other important factors was not possible because of the low number of trials. Where possible the analysis was stratified by parasite species (P. falciparum and P. vivax). Finally, consideration was given to the fact that in some areas the vector control activities have gone on for many years before the reported study, while in some other situations the investigated study introduced the vector control activities. While we have at present no way to assess the effect of this difference, areas having had vector control for a long time are clearly different from areas with no previous activities in many different aspects (entomological and human health parameters). Sensitivity analysis: There weren't sufficient trials to conduct a sensitivity analysis to investigate the robustness of the results.
Controlled before-and-after studies
We analysed the study in the same manner as RCTs and presented the results in tables.
Interrupted time series
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification.
Results of the search
We identified 134 potentially relevant studies. Of these we excluded 128 studies (for details of reasons see below and "Characteristics of excluded studies"). The remaining six studies met all the inclusion criteria. These trials are described below (for details see also "Characteristics of included studies").
Included studies Trial design and location
Out of the six included studies, four were RCTs (Curtis 1998; Misra 1999; Mnzava 2001; Rowland 2000) , and in all of these the allocation was by cluster (by villages, geographical blocks and sectors comprising several villages). One study was a CBA (Molineaux 1980) and one was an ITS (Sharp 2007). Four trials were conducted in sub-Saharan Africa: Tanzania Three trials were in areas with stable transmission (EIR>1) and three in areas with unstable transmission (EIR<1) ( Table 2) . 
Cointervention(s)
Pre-trial control measures 
Intervention
RCT:
One trial compared the impact of IRS versus the provision of ITNs to all inhabitants (Mnzava 2001). Two trials had three arms and compared the impact of IRS to the impact of ITN and to an untreated control zone (Curtis 1998; Misra 1999) . One trial studied the impact of IRS in comparison to a control area without any intervention (Rowland 2000) . For IRS, all studies used pyrethroids as insecticide. Two of them used deltamethrin (dosage = 20 mg/m²), and the two others lambdacyhalothrin (30 mg/m²) and alphacypermethrin (25 mg/m²). Since there is no evidence to suggest that there is a difference between these insecticides in terms of impact they were grouped for analysis. Two trials did not specifically report the spray coverage (Mnzava 2001; Curtis 1998) but oral communication from the investigators suggested coverage was "high"; for the other two (Misra 1999; Rowland 2000) coverage ranged from 92.2% to 96%. For treating ITNs, lambdacyhalothrin (10 mg/m² and 20 mg/m²), deltamethrin (25 mg/m²) and permethrin (200 mg/m²) were used. Again, available evidence (Lengeler 2004) does not suggest any difference in impact between these three pyrethroids. Coverage rates with ITNs ranged in two trials from 85.4% to 100% (Misra 1999; Mnzava 2001), while one trial didn not report coverage (Curtis 1998) but it was "high" since nets were given for free to the whole population (Curtis C. personal communication). In two of the three trials comparing IRS with ITNs (Mnzava 2001) IRS was done in the ITN areas before these were distributed. In the study area in KwaZulu-Natal there is a long history of IRS (around 50 years). Within the study area, all the houses in the ITN arm were sprayed in September 1996 before distributing the ITNs in January 1997. In subsequent years, house spraying was deliberately withdrawn in blocks with bed nets. In India (Misra 1999) there was a similar situation because of the long history of IRS in the study area, which started in 1953. IRS is nowadays a mainstay of malaria control in the study area.
CBA:
The impact of IRS was compared to a control area without any intervention (Molineaux 1980). Propoxur (2 g/m²) was used as insecticide. The spray coverage ranged from 74% to 100%. There was no history of IRS in the area before this trial.
ITS:
In the study of Sharp 2007 the change over time due to IRS was examined over the time period of two years before and five years after the introduction of IRS. The insecticide used was bendiocarb (400 mg/m²) and no usage coverage was mentioned. No history of IRS has been reported within the area before this study. Some additional characteristics of the trials are given in Table 2 .
Outcomes
Prevalence and incidence of malaria infections were the main outcomes that we could assess. See Table 3 for details. 
Excluded studies
One hundred and twenty-eight studies were excluded due to the following reasons (for details see table "Characteristics of excluded studies"):
• 40 did not have enough units/arm (minimum required: RCT: 3 clusters per arm, CBA: 2 clusters per arm)
• 22 did not have control sites which were comparable with the intervention sites • 8 used an insecticide or a dosage not recommended by WHO
• 12 were only reviews or conference abstracts and did not provide enough data
• 28 were ITS which did not provide enough data for pre-or post-intervention assessment • 14 were ITS using a mix of interventions • 2 trials did not collect contemporaneous data for the control and intervention sites • 5 measured non-eligible outcomes • 1 trial included refugees as study participants • 2 studies used a non-experimental approach (modelling) • 1 RCT had a randomized allocation of the intervention that was not acceptable
• 2 studies had an IRS coverage under 60% • 1 trial experienced a population movement of over 10% • 1 trial sprayed with DDT in an area with documented DDT resistant Anopheles.
Risk of bias in included studies
For an overview of the risk of bias see Figure 1 and Figure 2 . 
Allocation
Two of the four RCTs (Misra 1999; Mnzava 2001) generated allocation sequences by public drawing/tossing of coins. The risk of bias with these methods is low and allocation concealment is ensured by the fact that the allocation was made in public. The remaining two RCTs (Curtis 1998; Rowland 2000) don't specify how the randomization was done and how allocation concealment was secured. Therefore the risk for bias can't be assessed.
Blinding
Blinding is neither possible for IRS nor for ITNs and this criteria should therefore not be considered for assessing study quality. Given the type of interventions and the nature of the outcomes, the risk of bias resulting from the absence of blinding is judged as low.
Incomplete outcome data
Two of the six included trials (Misra 1999; Molineaux 1980) reported changes in the number of participants over time. In one trial (Misra 1999) the losses to follow-up were under 10% and therefore the risk of bias was considered to be low. In one other trial (Molineaux 1980), there was a large migration with 15% to 20% of the population changing per year. The migration was described in detail within the study. Furthermore, the study did an analysis to check for the risk of bias due to the population movements and it was considered to be low. The other trials didn't report on losses to follow-up. Since they were calculating "person-time-at-risk" as denominators the rates were accurate but the risk of selection bias over time could not be estimated.
Selective reporting
None of the studies contained enough information to permit a reliable judgment of the risk of this type of bias.
Other potential sources of bias
In one trial (ITS, Sharp 2007) all age categories were sampled in December 1999, but subsequent surveys were confined to children two to 14 years of age. Fortunately the authors gave details by age in the 1999 survey and hence this change did not matter. Mnzava 2001 compared IRS versus ITNs. However, houses in bed net blocks had already been sprayed by the time the nets were distributed in 2007. Even though there was immediately an effort by investigators to re-plaster these houses to cover the insecticide on the walls, the effect of ITNs might be overestimated due to the dual protection for a limited time. In subsequent years, house spraying was deliberately withdrawn in blocks with bed nets.
In the study of Misra 1999 a high incidence of plastering mud on the walls of houses was reported (Misra 1999) . This most likely reduced the effectiveness of IRS and hence underestimated its real effect. Unfortunately the authors don't provide detailed data on the replastering to allow a judgment on its impact. 
Effects of interventions
Incidence of infection:
Only one RCT assessed the impact of IRS against no IRS in a stable malaria setting: Curtis 1998 compared the impact of IRS with lambdacyhalothrin versus a control group with no intervention in a highly endemic malaria setting in Tanzania. In that trial IRS was shown to be effective in protecting children aged less than five years from reinfection with malaria parasites following radical cure: over an 11 month period, the PE was 54% (Table 4 ). In the same setting, malaria case incidence assessed by passive surveillance was probably reduced in children aged one to five years: PE 14%, but not in children older than five years: PE -2% (Table 4) . One CBA in Nigeria (Molineaux 1980) and one ITS in Mozambique (Sharp 2007) were also conducted in stable malaria settings but neither of these two trials measured incidence rates. However, Molineaux 1980 measured infant parasitological conversion rates and found a slight reduction in the areas with IRS compared to areas without (Table 5 ). (Table 4 ). In both Molineaux 1980 and Sharp 2007 the malaria prevalence was reduced where IRS was applied. However, Molineaux 1980 found a significant difference only for the prevalence rates during the wet season in which IRS showed a PE of 26% (95% CI 20 to 32%), while the PE in the dry season was only 6% (95% CI -4 to 15%) ( Table 6 ). In Mozambique (Sharp 2007), the prevalence rate dropped from 60 to 65% before the spraying to 4% in 2005 (Table 7) . On average the prevalence rate was 62% before spraying (939/1515) and 16% (638/3960) after, a reduction of 74%. (597) 60 (918) 38 (807) 22 (824) 8 (792) 7 (839) Anaemia: In Curtis 1998, the haemoglobin levels were significantly lower in the control group than in the IRS group (mean difference (MD) 0.85 g/dL; Table 8 ). Infant mortality rate: Molineaux 1980 measured infant mortality rates (IMR) but unfortunately without measuring it in a control area. They then derived evidence of impact from the close correlation between reduced infant parasitological conversion rates and IMR. It is unfortunate that because of this limitation these unique mortality data could not be used in our analysis.
Unstable malaria (EIR < 1)
Incidence of infection: IRS was shown to significantly reduce the incidence of malaria infections with a PE of 31% in India (Misra 1999) and 88% (95% CI 69 to 96%) in Pakistan (Rowland 2000; Table 9 ). IRS also reduced the incidence of malaria in a similar way when looking separately at P. falciparum (PE 93%, 95% CI 61 to 98% in Pakistan) and P. vivax (PE 79%, 95% CI 45 to 90% in Pakistan). (Table 9 ). For P. falciparum only, there was a reduction in prevalence in both India (PE 34%) and Pakistan (PE 92%) (Table 9 ). For P. vivax only, there was no impact in India (PE -2%) while there was a significant PE of 68% in Pakistan (Table 9 ).
Comparison 2: IRS versus Insecticide Treated Nets (ITNs)
Stable malaria (EIR > 1)
Incidence of infection: only one RCT was done in an area of stable transmission (Curtis 1998). When comparing parasitological reinfection rates after radical cure in short-term cohorts, ITNs had a tendency for a greater protective effect than IRS in that Tanzanian trial (risk ratio IRS:ITN = 1.22, CI not adjusted for clustering) (Table 10 ). When the incidence rate of malaria episodes was measured by passive case detection, there was no difference detectable in children aged one to five years: risk ratio 0.88 (upper unadjusted CI approached 1). No difference was seen for children older than five years: risk ratio 0.98 (Table 10) .
Prevalence of infection:
In Curtis 1998 prevalence rates were found to be no different within the IRS and ITN groups: risk ratio 1.06 (Table 10) .
No difference in haemoglobin levels were detected either: MD 0.06 g/dL (Table 8) .
Unstable malaria (EIR < 1)
Incidence of infection: Misra 1999 found a significant difference between IRS and ITNs: risk ratio IRS:ITN = 1.48 (95% CI 1.37 to 1.60), but Mnzava 2001 did not because the 95% CI were large: risk ratio 1.34 (cluster unadjusted CI 95% 0.77 to 2.70) (Table  11) . 
D I S C U S S I O N
Since the 1950s, IRS has been used widely in many areas of the world, especially in Asia, Latin America and Southern Africa. IRS with DDT and other insecticides has been one of the main interventions leading to the elimination of malaria in about half of the world's regions, for example in much of southern Europe, North America, Japan, Central Asia and Latin America and it is still being widely used (Lengeler 2003; WHO 2008) . Very low levels of malaria transmission have also been achieved and maintained in countries as different as India, Tadjikistan and Colombia. Hence the effectiveness of this intervention is beyond doubt. Unfortunately, the epidemiological effect has never been quantified properly, so that a comparison with other malaria control interventions, for example with ITNs, is impossible. As a result, an accurate comparative cost-effectiveness assessment is also impossible. (2) is there any benefit in combining both IRS and ITNs together to increase impact, especially in view of the goal of malaria elimination declared in 2007?
While there are now good data on comparative feasibility and cost (see review by Yukich 2008), the present review confirms the paucity of high-quality evidence in the comparative assessment of health impact. There are too few high-quality randomized controlled studies on the health effects of IRS, and not enough geographical coverage. Only six out of 134 identified studies met our inclusion criteria (four RCTs, one CBA and one ITS) and not all key malariological outcomes were addressed within these studies. Unfortunately, none of the studies investigated the potential of IRS for reducing child mortality rates. In some ways, these results are not entirely surprising considering the fact that (1) IRS started to be implemented on a large scale after the invention of DDT in 1943 (and hence before the first RCT conducted in 1948), and (2) IRS with DDT was outstanding in its health effects from the start, therefore giving no strong rationale for public health officials in the 1950s and 1960s to formally test its effects.
Currently, our evidence on the question of the impact of the combination of IRS with ITNs is also very limited. A recent review (Kleinschmidt 2009) has suggested some additive effects but the evidence only stems from descriptive studies, and properly conducted RCTs are urgently required.
Overall, the formal quality of the six included trials was considered to be satisfactory. Two of the four RCTs used appropriate methods for sequence generation and allocation concealment, whereas the other two trials didn't mention their procedure. However, given the nature of the intervention and the fact that it was allocated by cluster, this is unlikely to have led to bias in the results. Due to the nature of the intervention, blinding was not possible, but no risk of bias was expected because of this.
A much bigger issue for the validity of the results is the implementation of the interventions.In three (Misra 1999; Mnzava 2001; Rowland 2000) of the four RCTs, the control and/or ITN arms of the trials had a long previous history of IRS, and spraying was simply suspended in the ITN arm for the duration of the trial. Obviously, the entomological baseline situation was not any more that of an untouched area. In addition, insecticide was sprayed shortly before ITN distribution in the ITN arms in India and Tanzania. Despite the best efforts by investigators to minimize the effects of this by re-plastering the walls, that interference is still likely to have had an independent effect on the outcomes. Unfortunately, it is impossible to quantify these effects.
Only two different classes of insecticides (carbamates and pyrethroids) were used in the reviewed trials, to which the mosquitoes were fully susceptible in all settings. Insecticide resistance is an obvious threat to the effectiveness of IRS. However, unlike 50 years ago, when DDT was the only insecticide on hand, there are now 12 different insecticides within four different chemical classes available for IRS. This gives the possibility to alternate the insecticides and to switch to other insecticides in case of emerging resistance. This is a clear advantage over ITNs, for which only one class of insecticide is available (pyrethroids). On the other hand, ITNs still offer a physical barrier to the vector, even if the insecticide doesn't work anymore, whereas for IRS the protection through the insecticide will be strongly reduced.
The low number of trials unfortunately prevented us from carrying out any form of sub-group analysis, which would have included the impact of different types of insecticides, the length of the transmission season, the type of vectorial systems and other factors thought to be important.
The four included randomized controlled trials were distributed between Asia and sub-Saharan Africa. Only one RCT was done in a stable malaria setting (EIR >1, Curtis 1998). Three RCTs were done in unstable malaria settings (EIR <1). Two of them were in Asia (Misra 1999 (India); Rowland 2000 (Pakistan)) and one in Africa (Mnzava 2001 (South Africa)).
Comparing IRS to no IRS in stable settings, in the study in Tanzania (Curtis 1998) the risk for children under six to get re-in-fected with malaria parasites after radical cure was reduced approximately by half (PE: 54%), an indication that IRS reduced malaria transmission. Paradoxically, no changes was observed in malaria incidence rates when cases were detected by passive surveillance (without initial parasite clearance). Possibly, the clearance of all infections with an effective antimalarial (chlorproguanil-dapsone), something not usually done in vector control trials, had an additional independent effect. Hence, the generalization of these results to other malaria endemic areas needs to be questioned.
For IRS versus no IRS in unstable areas, the trials from India and Pakistan both showed that IRS protected all age groups and for both P. falciparum and P. vivax in these settings from malaria infections.
When comparing IRS versus ITNs, in the one trial in a stable area Curtis 1998 there was a trend towards ITNs having a greater PE than IRS on incidence after radical cure but the unadjusted CIs approached 1 (risk ratio IRS:ITN = 1.22). However, when the incidence was measured by passive case detection, there was a slight but non significant difference in favour of IRS in children aged one to five years (risk ratio = 0.88). No difference was found for malaria prevalence or haemoglobin.
ITN appeared to be more protective than IRS in unstable areas. For malaria prevalence, ITNs appeared to give better protection against any infection compared to IRS in India.
The results of this review do not reconcile well with the impressive historical reductions of malaria in many areas of the world following the introduction of IRS. Among these areas were also a number of high transmission areas in sub-Saharan Africa (Kouznetsov 1977; Mabaso 2004) . In part this discrepancy could be explained by the fact that programmes were conducted on a much larger scale and for a much longer time period than trials, with a resulting better impact. Hence, the lack of positive evidence from formal trials should not, in the case of IRS, be interpreted as a lack of effect of the intervention. Rather, it is the consequence of a lack of high-quality and long-duration trials on a large scale done in areas not previously under vector control. As a result, the main aim of the review (to quantify the health effects of IRS) could not be achieved and our major conclusion is that high-quality evidence from RCTs is still required. For obvious ethical reasons a control group without vector control intervention is not acceptable any more and such trials should therefore have at least two arms, an IRS arm and an ITN arm. Given the importance of also assessing the combined effect of IRS and ITNs, a third arm with both interventions together would be highly desirable.
A U T H O R S ' C O N C L U S I O N S Implications for practice
• The current evidence is insufficient to quantify properly the effect of IRS in high transmission settings although it seems clear that IRS leads to health benefits.
• Available good quality evidence confirms that IRS works in reducing malaria in unstable malaria settings.
• At present, a quantitative epidemiological comparison between IRS and ITNs is not possible.
• No trial investigated the effect of IRS in reducing (child) mortality.
• There is insufficient epidemiological evidence to assess the effect of other determinants of impact, such as the insecticide class used for IRS, the type of transmission, the dominant vector species and socio-cultural determinants.
Implications for research
• There is an urgent need for more RCTs comparing IRS with ITNs in a number of settings with different epidemiological and socio-cultural characteristics.
• Ideally, such RCTs should have a third arm with a combination of high coverage IRS with high coverage ITNs; each arm should at least have 3 to 5 large-size clusters.
• Participants of all age-groups should be included in such trials.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Curtis 1998
Methods 1996) .
Incidence of re-infection was monitored once before the interventions and four times after introduction of intervention (once in each quarter of 1996) by taking weekly blood slides. Cross-sectional surveys were carried out monthly from April 1995 to December 1996. In addition, a passive surveillance system was set up. People feeling sick with fever were encouraged to visit a local research assistant, who was taking a blood slide from them, which were collected weekly. Different children were used for each cohort. Confidence intervals were not adjusted for clustering. We could retrospectively adjust for the prevalence, but not for the incidence data.
Participants
Number of participants: Incidence: 60:60:60 (control:ITNs:IRS), prevalence: 104:93:86, passive surveillance: 500:357:795. Inclusion criteria: incidence: children aged 1 to 6 with cleared pre-existing parasitaemia; prevalence: children aged 1 to 6, passive surveillance: people of all ages feeling sick with fever. Exclusion criteria: incidence: children away from home, for having missed the blood slide for more than 1 week; prevalence: children already included in the incidence group, children which were selected in the previous month and children with parasitaemia >4000/µl. Passive surveillance: no specific exclusion criteria mentioned.
Interventions IRS: Microencapsulated lambdacyhalothrin (ICON™) 10%; dosage: 30 mg/m². The wall and roof areas were sprayed with Hudson X-Pert spray pumps. Re-spraying in the villages was carried out seven to eight months after the initial spraying (July to August 1996). The spray coverage was not specifically mentioned but maximal coverage was aimed for. ITNs: Lambdacyhalothrin (ICON™); dosage: 10 mg/m² in 2 villages, and 20 mg/ m² in the other 2 villages. Retreatment after seven months. The coverage rate was not specifically mentioned.
Outcomes
(1) Incidence of re-infection after parasitological clearance with antimalarials (2) Incidence rates by passive case detection ( Length of follow-up: 2 months before intervention and 7 months after spraying done in June 1997 (one season). Active case detection by home visits every fortnight. Blood slides were taken from any member of a household reporting to having had fever during the previous three days. Monitoring from April 1997 to January 1998, covering the entire malaria transmission season. Two cross-sectional surveys were carried out in April-May and September 1997, i.e. before and after the spraying, which was done in June 1997 (one survey within and one survey outside the malaria season, which runs from June to November). To assess the prevalence rate, blood slides were taken from children of one or two schools selected from sentinel villages in each sector. Drop-out rates unknown. Confidence intervals were not adjusted for clustering by authors. We could adjust the incidence and prevalence data retrospectively. See Data collection and analysis for more details.The rate ratio (RR) of IRS vs no IRS was estimated by a generalized linear model with negative binomial mean and variance functions. This model sowed to best fit the observed cluster-level incidence rates (Generalized Pearson statistics=1.29).
Participants
(1) Active case detection: Number enrolled:18,000 (2000 in each of the 9 sectors). Inclusion criteria into active surveillance group: any member of a household who reported having had fever during the previous 3 days. Exclusion criteria: No explicit exclusion (all ages).
(2) Cross-sectional surveys: Inclusion criteria: School children aged 5 to 15 years present in school on the day of the 
Interventions
Alpha-cypermethrin WP and SC; dosage 25 mg/m²; living quarters, storage rooms and animals shelters were sprayed with Hudson X-pert spray pumps Spray coverage: WP: 96%, SC: 97%.
Outcomes
(1) Malaria incidence through active case detection (P. falciparum and P. vivax).
(2) Malaria prevalence through cross-sectional surveys (P. falciparum and P. vivax). 
Notes
Free of selective reporting? Unclear
There is insufficient information to permit a judgement.
Free of other bias? No Quote 1: "IRS was interrupted from 2001 to 2002 because of resource constraints, but resumed in the second half of 2003". Comment: Due to the interruption of IRS, it is likely that the effect of the spraying will be underestimated. Quote 2: "All age categories were sampled in December 1999, and subsequent surveys were confined to children two to 14 years of age". Comment: In a malaria endemic area, the
D A T A A N D A N A L Y S E S
This review has no analyses. 
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